AGN 0.68% 73.5¢ argenica therapeutics limited

Ann: Positive DSMB Safety Outcome & Phase 2 Trial Progress Update, page-23

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 268 Posts.
    lightbulb Created with Sketch. 25
    I’ll post something for you that again tells you something to tell you that these peptides go through so much potential but fail always to get a functional effect even AGN. Don’t be a smart as because these peptide drugs have been around for 10-15 years. NA-1 was the exact same functional effect was never achieved. Relax let phase 2 play out already these peptides give great results so our share price will react positively. Still think we have $2-$3 on phase 2 potential.


    https://hotcopper.com.au/data/attachments/6440/6440682-df9dcf97ab42cc95f4f1fa244414fd31.jpg
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.